97 related articles for article (PubMed ID: 24747679)
1. Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma.
Sanz Rubiales A; de la Cruz V; Berezo JÁ; Torres MÁ
J Pain Symptom Manage; 2014 Jun; 47(6):e7-9. PubMed ID: 24747679
[No Abstract] [Full Text] [Related]
2. The use of octreotide to manage symptoms of bronchorrhea: a case report.
Pahuja M; Shepherd RW; Lyckholm LJ
J Pain Symptom Manage; 2014 Apr; 47(4):814-8. PubMed ID: 24035070
[TBL] [Abstract][Full Text] [Related]
3. Prompt control of bronchorrhea in patients with bronchioloalveolar carcinoma treated with gefitinib (Iressa).
Milton DT; Kris MG; Gomez JE; Feinstein MB
Support Care Cancer; 2005 Jan; 13(1):70-2. PubMed ID: 15558327
[TBL] [Abstract][Full Text] [Related]
4. Severe bronchorrhea in a patient with bronchioloalveolar carcinoma.
Popat N; Raghavan N; McIvor RA
Chest; 2012 Feb; 141(2):513-514. PubMed ID: 22315118
[TBL] [Abstract][Full Text] [Related]
5. Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports.
Kitazaki T; Fukuda M; Soda H; Kohno S
Lung Cancer; 2005 Jul; 49(1):125-8. PubMed ID: 15949598
[TBL] [Abstract][Full Text] [Related]
6. Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin.
Suga T; Sugiyama Y; Fujii T; Kitamura S
Eur Respir J; 1994 Dec; 7(12):2249-51. PubMed ID: 7713212
[TBL] [Abstract][Full Text] [Related]
7. [Gefitinib for advanced bronchioloalveolar carcinoma].
Zhang XT; Wang SL; Li LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):340-3. PubMed ID: 15266843
[TBL] [Abstract][Full Text] [Related]
8. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Wislez M; Antoine M; Baudrin L; Poulot V; Neuville A; Pradere M; Longchampt E; Isaac-Sibille S; Lebitasy MP; Cadranel J
Lung Cancer; 2010 May; 68(2):185-91. PubMed ID: 19581016
[TBL] [Abstract][Full Text] [Related]
9. Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation.
Taja-Chayeb L; Candelaria M; Brom R; Trejo-Becerril C; Meza F; Duenas-Gonzalez A
Lung Cancer; 2005 Nov; 50(2):259-63. PubMed ID: 16009451
[TBL] [Abstract][Full Text] [Related]
10. Resection of mucinous lung adenocarcinoma presenting with intractable bronchorrhea.
Takao M; Takagi T; Suzuki H; Shimamoto A; Murashima S; Taguchi O; Shimpo H
J Thorac Oncol; 2010 Apr; 5(4):576-8. PubMed ID: 20357626
[No Abstract] [Full Text] [Related]
11. [Efficacy of gefitinib (Iressa) in the treatment of an inoperable bronchioloalveolar cell carcinoma].
Bayle S; Descourt R; Gouva S; Daniel C; Robinet G
Rev Mal Respir; 2004 Feb; 21(1):153-7. PubMed ID: 15260051
[TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar carcinoma accompanied by severe bronchorrhea.
Hidaka N; Nagao K
Chest; 1996 Jul; 110(1):281-2. PubMed ID: 8681643
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma.
Homma S; Kawabata M; Kishi K; Tsuboi E; Narui K; Nakatani T; Nakata K
Chest; 1999 May; 115(5):1465-8. PubMed ID: 10334175
[TBL] [Abstract][Full Text] [Related]
14. Bronchioloalveolar carcinoma: not as easy as "BAC".
West HL; Garfield DH
J Thorac Oncol; 2009 Sep; 4(9):1047-8. PubMed ID: 19704334
[No Abstract] [Full Text] [Related]
15. [A case of bronchioloalveolar carcinoma successfully treated with low-dose, alternate-day administration of erlotinib].
Yuyama K; Matsushita H; Egawa K; Osawa T; Tsubouchi Y; Takahashi T; Miura H
Gan To Kagaku Ryoho; 2012 Mar; 39(3):433-5. PubMed ID: 22421774
[TBL] [Abstract][Full Text] [Related]
16. Lung perfusion in bronchiolo-alveolar carcinoma. A case report.
Wolinsky H; Lin A; Williams MH
Am Rev Respir Dis; 1969 Apr; 99(4):585-9. PubMed ID: 4305745
[No Abstract] [Full Text] [Related]
17. Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9.
Nakajima T; Terashima T; Nishida J; Onoda M; Koide O
Intern Med; 2002 Mar; 41(3):225-8. PubMed ID: 11929186
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
Argiris A; Mittal N
Lung Cancer; 2004 Mar; 43(3):317-22. PubMed ID: 15165090
[TBL] [Abstract][Full Text] [Related]
19. Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive to erlotinib.
Manson GV; Ma PC
Clin Lung Cancer; 2010 Jan; 11(1):57-60. PubMed ID: 20085869
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
West HL; Franklin WA; McCoy J; Gumerlock PH; Vance R; Lau DH; Chansky K; Crowley JJ; Gandara DR
J Clin Oncol; 2006 Apr; 24(12):1807-13. PubMed ID: 16622257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
